Catalyst
Slingshot members are tracking this event:
EMA Decision on Supplemental Application for Portola's (PTLA) Andexxa (Andexanet Alfa) Expected in First Half of 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTLA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 20, 2018
Occurred Source:
http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2333529
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ema, European Medicines Agency, Supplemental Application, Andexxa, Andexanet Alfa, Serious Uncontrolled Bleeding Event, Urgent, Emergent Surgery
